101 results on '"van Os R"'
Search Results
2. Stereotactic ablative radiotherapy or best supportive care in patients with localized pancreatic cancer not receiving chemotherapy and surgery (PANCOSAR): a nationwide multicenter randomized controlled trial according to a TwiCs design
- Author
-
Doppenberg, D., Besselink, M. G., van Eijck, C. H. J., Intven, M. P. W., Koerkamp, B. Groot, Kazemier, G., van Laarhoven, H. W. M., Meijerink, M., Molenaar, I. Q., Nuyttens, J. J. M. E., van Os, R., van Santvoort, H. C., van Tienhoven, G., Verkooijen, H. M., Versteijne, E., Wilmink, J. W., Lagerwaard, F. J., and Bruynzeel, A. M. E.
- Published
- 2022
- Full Text
- View/download PDF
3. Stereotactic ablative radiotherapy or best supportive care in patients with localized pancreatic cancer not receiving chemotherapy and surgery (PANCOSAR):a nationwide multicenter randomized controlled trial according to a TwiCs design
- Author
-
Doppenberg, D., Besselink, M. G., van Eijck, C. H.J., Intven, M. P.W., Koerkamp, B. Groot, Kazemier, G., van Laarhoven, H. W.M., Meijerink, M., Molenaar, I. Q., Nuyttens, J. J.M.E., van Os, R., van Santvoort, H. C., van Tienhoven, G., Verkooijen, H. M., Versteijne, E., Wilmink, J. W., Lagerwaard, F. J., Bruynzeel, A. M.E., Doppenberg, D., Besselink, M. G., van Eijck, C. H.J., Intven, M. P.W., Koerkamp, B. Groot, Kazemier, G., van Laarhoven, H. W.M., Meijerink, M., Molenaar, I. Q., Nuyttens, J. J.M.E., van Os, R., van Santvoort, H. C., van Tienhoven, G., Verkooijen, H. M., Versteijne, E., Wilmink, J. W., Lagerwaard, F. J., and Bruynzeel, A. M.E.
- Abstract
Background: Significant comorbidities, advanced age, and a poor performance status prevent surgery and systemic treatment for many patients with localized (non-metastatic) pancreatic ductal adenocarcinoma (PDAC). These patients are currently treated with ‘best supportive care’. Therefore, it is desirable to find a treatment option which could improve both disease control and quality of life in these patients. A brief course of high-dose high-precision radiotherapy i.e. stereotactic ablative body radiotherapy (SABR) may be feasible. Methods: A nationwide multicenter trial performed within a previously established large prospective cohort (the Dutch Pancreatic cancer project; PACAP) according to the ‘Trial within cohorts’ (TwiCs) design. Patients enrolled in the PACAP cohort routinely provide informed consent to answer quality of life questionnaires and to be randomized according to the TwiCs design when eligible for a study. Patients with localized PDAC who are unfit for chemotherapy and surgery or those who refrain from these treatments are eligible. Patients will be randomized between SABR (5 fractions of 8 Gy) with ‘best supportive care’ and ‘best supportive care’ only. The primary endpoint is overall survival from randomization. Secondary endpoints include preservation of quality of life (EORTC-QLQ-C30 and -PAN26), NRS pain score response and WHO performance scores at baseline, and, 3, 6 and 12 months. Acute and late toxicity will be scored using CTCAE criteria version 5.0: assessed at baseline, day of last fraction, at 3 and 6 weeks, and 3, 6 and 12 months following SABR. Discussion: The PANCOSAR trial studies the added value of SBRT as compared to ‘best supportive care’ in patients with localized PDAC who are medically unfit to receive chemotherapy and surgery, or refrain from these treatments. This study will assess whether SABR, in comparison to best supportive care, can relieve or delay tumor-related symptoms, enhance quality of life, and extend survival
- Published
- 2022
4. Stereotactic ablative radiotherapy or best supportive care in patients with localized pancreatic cancer not receiving chemotherapy and surgery (PANCOSAR): a nationwide multicenter randomized controlled trial according to a TwiCs design
- Author
-
MS Radiotherapie, Cancer, CTC, MS CGO, MS HOD, Trialbureau Beeld, Arts-assistenten Radiotherapie, Doppenberg, D., Besselink, M. G., van Eijck, C. H.J., Intven, M. P.W., Koerkamp, B. Groot, Kazemier, G., van Laarhoven, H. W.M., Meijerink, M., Molenaar, I. Q., Nuyttens, J. J.M.E., van Os, R., van Santvoort, H. C., van Tienhoven, G., Verkooijen, H. M., Versteijne, E., Wilmink, J. W., Lagerwaard, F. J., Bruynzeel, A. M.E., MS Radiotherapie, Cancer, CTC, MS CGO, MS HOD, Trialbureau Beeld, Arts-assistenten Radiotherapie, Doppenberg, D., Besselink, M. G., van Eijck, C. H.J., Intven, M. P.W., Koerkamp, B. Groot, Kazemier, G., van Laarhoven, H. W.M., Meijerink, M., Molenaar, I. Q., Nuyttens, J. J.M.E., van Os, R., van Santvoort, H. C., van Tienhoven, G., Verkooijen, H. M., Versteijne, E., Wilmink, J. W., Lagerwaard, F. J., and Bruynzeel, A. M.E.
- Published
- 2022
5. Loss of Tcf 7 diminishes hematopoietic stem/progenitor cell function
- Author
-
Huls, G, van Es, J, Clevers, H, de Haan, G, and van Os, R
- Published
- 2013
- Full Text
- View/download PDF
6. Brachytherapy after external beam radiotherapy and limited surgery preserves bladders for patients with solitary pT1–pT3 bladder tumors
- Author
-
Koning, C. C. E., Blank, L. E. C. M., Koedooder, C., van Os, R. M., van de Kar, M., Jansen, E., Battermann, J. J., Beijert, M., Gernaat, C., van Herpen, K. A. M., Hoekstra, C., Horenblas, S., Jobsen, J. J., Krol, A. D. G., Lybeert, M. L. M., van Onna, I. E. W., Pelger, R. C. M., Poortmans, P., Pos, F. J., van der Steen-Banasik, E., Slot, A., Visser, A., and Pieters, B. R.
- Published
- 2012
- Full Text
- View/download PDF
7. Increased rejection of murine allogeneic bone marrow in presensitized recipients
- Author
-
van Os, R, de Witte, T, Dillingh, JH, Mauch, PM, and Down, JD
- Published
- 1997
- Full Text
- View/download PDF
8. Find drugs that delay many diseases of old age
- Author
-
Bellantuono, I., DeCabo, R., Ehninger, D., Fernandes, A., Howlett, S.E., Müller, R., Potter, P., Tchkonia, T., Trendelenburg, A.-U., Trejo, J.L., Vandenbroucke, R., van Os, R., van Riel, N.A.W., and Computational Biology
- Subjects
0301 basic medicine ,Gerontology ,Aging ,Time Factors ,Frail Elderly/statistics & numerical data ,ComputingMilieux_LEGALASPECTSOFCOMPUTING ,SDG 3 – Goede gezondheid en welzijn ,Biomarkers, Pharmacological ,Mice ,0302 clinical medicine ,Neoplasms ,Health care ,80 and over ,Aged, 80 and over ,Multidisciplinary ,biology ,Rejuvenation/physiology ,Aging/drug effects ,Chronic Disease/epidemiology ,Diabetes Mellitus/epidemiology ,Age distribution ,Psychology ,Longevity/drug effects ,Frail Elderly ,Longevity ,MEDLINE ,03 medical and health sciences ,Alzheimer Disease/epidemiology ,Age Distribution ,SDG 3 - Good Health and Well-being ,Alzheimer Disease ,Diabetes Mellitus ,Animals ,Humans ,Rejuvenation ,Resilience (network) ,Aged ,Animal ,business.industry ,Pharmacological ,Multimorbidity ,biology.organism_classification ,Disease Models, Animal ,030104 developmental biology ,Ilaria ,Disease Models ,Chronic Disease ,business ,Neoplasms/epidemiology ,Biomarkers ,030217 neurology & neurosurgery - Abstract
Simply extending lifespan is not enough. We need treatments that boost resilience to multiple age-related diseases, argue Ilaria Bellantuono and 12 co-signatories. Simply extending lifespan is not enough. We need treatments that boost resilience to multiple age-related diseases, argue Ilaria Bellantuono and 12 co-signatories.
- Published
- 2018
9. Progression of hearing loss after LINAC-based stereotactic radiotherapy for vestibular schwannoma is associated with cochlear dose, not with pre-treatment hearing level
- Author
-
van Linge, A., primary, van Os, R., additional, Hoekstra, N., additional, Heijmen, B., additional, Stienstra, L., additional, Dallenga, A., additional, Wolbers, J., additional, and Mendez Romero, A., additional
- Published
- 2018
- Full Text
- View/download PDF
10. Loss of Tcf7 diminishes hematopoietic stem/progenitor cell function
- Author
-
Huls, G, van Es, J, Clevers, H, de Haan, G, and van Os, R
- Published
- 2013
- Full Text
- View/download PDF
11. Progression of hearing loss after LINAC-based stereotactic radiotherapy for vestibular schwannoma is associated with cochlear dose, not with pre-treatment hearing level
- Author
-
Linge, Anne, van Os, R, Hoekstra, Nienke, Heijmen, Ben, Stienstra, Linda, Dallenga, Alof, Wolbers, JG, Mendez Romero, Alejandra, Linge, Anne, van Os, R, Hoekstra, Nienke, Heijmen, Ben, Stienstra, Linda, Dallenga, Alof, Wolbers, JG, and Mendez Romero, Alejandra
- Published
- 2018
12. What drives ‘soft deportation’? Understanding the rise in Assisted Voluntary Return among rejected asylum seekers in the Netherlands
- Author
-
Leerkes, Arjen, van Os, R, Boersema, E, and Sociology
- Published
- 2017
13. P2.17-10 Daily Low–Dose Cisplatin and High Dose Radiotherapy for Elderly Patients with Stage III NSCLC is Well Tolerated.
- Author
-
Dieleman, E.m.t., primary, Van Os, R., additional, Kolff, W., additional, Koning, C.c.e., additional, Annema, J.t., additional, and Rasch, C.r.n., additional
- Published
- 2018
- Full Text
- View/download PDF
14. What drives 'soft deportation'? Understanding the rise in Assisted Voluntary Return among rejected asylum seekers in the Netherlands
- Author
-
Leerkes, A.S. (Arjen), van Os, R. (Rianne), Boersema, E. (Eline), Leerkes, A.S. (Arjen), van Os, R. (Rianne), and Boersema, E. (Eline)
- Abstract
States experience difficulties in realizing the return of rejected asylum seekers, but migration control policies are becoming increasingly sophisticated. Against this background, we consider explanations for the increase in Assisted Voluntary Return from the Netherlands in the 2005-2011 period. Both macro-level factors (source country societal conditions and characteristics of the Dutch "deportation regime") and individual-level factors (applicants' demographic characteristics and variation in status determination time) are examined. The study, which is based on a unique multilevel dataset (N = 15,682) with data from governmental and other sources (including International Organisation for Migration), is the first to quantitatively test assumed Assisted Voluntary Return determinants and contributes to the study of policy effects in migration studies. We find that states are capable of increasing return rates by expanding the use of "hard" and "soft" power. We propose the term "soft deportation" as a way to go beyond the dichotomy of "voluntary" and "forced" return.
- Published
- 2017
- Full Text
- View/download PDF
15. Frailty in mouse ageing: A conceptual approach
- Author
-
von Zglinicki T, Nieto I, Brites D, Karagianni N, Ortolano S, Georgopoulos S, Cardoso A, Novella S, Lepperdinger G, Trendelenburg A, and van Os R
- Abstract
Human life expectancy has increased dramatically in the last century and as a result also the prevalence of a variety of age-related diseases and syndromes. One such syndrome is frailty, which is defined as a combination of organ dysfunctions leading to increased vulnerability to adverse health outcomes. In humans, frailty is associated with various biomarkers of ageing and predicts relevant outcomes such as responses to therapies and progression of health status and mortality. Moreover, it is relatively easy to assess. To foster translation of mechanistic understanding of the ageing process and, importantly, of interventions that may extend healthy lifespan, frailty scales have been reverse translated into mice in recent years. We will review these approaches with a view to identify what is known and what is not known at present about their validity, reproducibility and reliability with a focus on the potential for further improvement. (C) 2016 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-NC-ND license.
- Published
- 2016
16. Afgewezen en uit Nederland vertrokken? Een onderzoek naar de achtergronden van variatie in zelfstandige terugkeer onder uitgeprocedeerde asielzoekers
- Author
-
Leerkes, Arjen, Boersema, E, Galloway, M, van Os, R, Van Londen, M, and Sociology
- Published
- 2014
17. Het realiseren van een maakbaar detail: door bruikbare, uitvoerbare en volledige werkinstructies en details
- Author
-
van Os, R. and van Os, R.
- Published
- 2015
18. PFTijah: text search in an XML database system
- Author
-
Hiemstra, Djoerd, Rode, H., van Os, R., Flokstra, Jan, and Databases (Former)
- Subjects
EWI-8847 ,ComputingMethodologies_DOCUMENTANDTEXTPROCESSING ,IR-66798 ,METIS-237828 - Abstract
This paper introduces the PFTijah system, a text search system that is integrated with an XML/XQuery database management system. We present examples of its use, we explain some of the system internals, and discuss plans for future work. PFTijah is part of the open source release of MonetDB/XQuery.
- Published
- 2006
19. Stem cell assays: Something old, something new, something borrowed: Something old, something new, something borrowed
- Author
-
van Os, R., Kamminga, Leonie, and de Haan, G.
- Subjects
CULTURE-INITIATING CELLS ,competitor ,LIVER-REGENERATION ,IN-VITRO ,assay ,FUNCTIONAL-PROPERTIES ,BONE-MARROW-CELLS ,SELF-RENEWAL ,competitive repopulation ,stem cells ,LIMITING-DILUTION ,reconstitution ,SKELETAL-MUSCLE ,HEMATOPOIETIC-CELLS ,TERM REPOPULATING ABILITY - Abstract
Numerous assays exist that measure the function of stem cells. In this article, we review in detail the history and future of existing stem cell assays. Hematopoietic stem cells (HSCs) are historically the most well studied, but new developments in stem cell research, including the claim of stem cell plasticity, have caused controversies related to technical issues, as well as to semantics. Stem cell research requires proper definitions, and utilization of stem cell assays, especially since research on non-HSCs that lack solid stem cell assays, is rapidly evolving. These emerging fields may benefit from what has been learned from HSC assays: most important, that the true potential of stem cells can only be assessed retrospectively. This also relates to new developments in HSC research, when limiting numbers of in vitro–manipulated stem cells are transplanted. The most conflicting results arise when cells express stem cell characteristics in one assay but not in another. Should we adjust our definition of a stem cell? If so, when do we decide a claim of stem cell activity to be justified? We therefore recommend using multiple stem cell assays, preferably at least one in vivo assay. These assays should measure functionality of the putative stem cell population.
- Published
- 2004
20. Loss of Tcf7 diminishes hematopoietic stem/progenitor cell function
- Author
-
Huls, G., van Es, J., Clevers, H., de Haan, G., van Os, R., Huls, G., van Es, J., Clevers, H., de Haan, G., and van Os, R.
- Published
- 2013
21. Loss of Tcf7 diminishes hematopoietic stem/progenitor cell function
- Author
-
Huls, G, primary, van Es, J, additional, Clevers, H, additional, de Haan, G, additional, and van Os, R, additional
- Published
- 2012
- Full Text
- View/download PDF
22. Professionalisering en personalisering?:De sites van Nederlandse partijen en hun kandidaten bij de campagne voor de Europese verkiezingen van 2004
- Author
-
Hagemann, C.P.M., Voerman, Gerrit, Hagemann, C.P.M., van Os, R. G., Jankowski, N.W., Hagemann, C.P.M., Voerman, Gerrit, Hagemann, C.P.M., van Os, R. G., and Jankowski, N.W.
- Published
- 2005
23. Professionalisering en personalisering?:De sites van Nederlandse partijen en hun kandidaten bij de campagne voor de Europese verkiezingen van 2004
- Author
-
Voerman, Gerrit, Hagemann, C.P.M., van Os, R. G., Jankowski, N.W., Voerman, Gerrit, Hagemann, C.P.M., van Os, R. G., and Jankowski, N.W.
- Published
- 2005
24. Radiation dose-fractionation and dose-rate relationships for long-term repopulating hemopoietic stem cells in a murine bone marrow transplant model: Reply
- Author
-
Down, JD, van Os, R, Konings, AWT, Ploemacher, RE, and THAMES, HD
- Subjects
ENGRAFTMENT ,TOTAL-BODY IRRADIATION ,CYCLOPHOSPHAMIDE - Published
- 1994
25. Targeted disruption of the cell-cycle checkpoint gene ATR leads to early embryonic lethality in mice
- Author
-
de Klein, A., primary, Muijtjens, M., additional, van Os, R., additional, Verhoeven, Y., additional, Smit, B., additional, Carr, A.M., additional, Lehmann, A.R., additional, and Hoeijmakers, J.H.J., additional
- Published
- 2000
- Full Text
- View/download PDF
26. Variations in radiation sensitivity and repair among different hematopoietic stem cell subsets following fractionated irradiation
- Author
-
Down, JD, primary, Boudewijn, A, additional, van Os, R, additional, Thames, HD, additional, and Ploemacher, RE, additional
- Published
- 1995
- Full Text
- View/download PDF
27. Accelerated high-dose radiotherapy alone or combined with either concomitant or sequential chemotherapy; treatments of choice in patients with Non-Small Cell Lung Cancer
- Author
-
Pieters Bradley R, van de Kar Marlou, Koedooder Kees, van Os Rob M, Koolen Mia GJ, Uitterhoeve Apollonia LJ, and Koning Caro CE
- Subjects
Medical physics. Medical radiology. Nuclear medicine ,R895-920 ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
Abstract Background Results of high-dose chemo-radiotherapy (CRT), using the treatment schedules of EORTC study 08972/22973 or radiotherapy (RT) alone were analyzed among all patients (pts) with Non Small Cell Lung Cancer (NSCLC) treated with curative intent in our department from 1995–2004. Material Included are 131 pts with medically inoperable or with irresectable NSCLC (TNM stage I:15 pts, IIB:15 pts, IIIA:57 pts, IIIB:43 pts, X:1 pt). Treatment Group I: Concomitant CRT: 66 Gy/2.75 Gy/24 fractions (fx)/33 days combined with daily administration of cisplatin 6 mg/m2: 56 pts (standard). Group II: Sequential CRT: two courses of a 21-day schedule of chemotherapy (gemcitabin 1250 mg/m2 d1, cisplatin 75 mg/m2 d2) followed by 66 Gy/2.75 Gy/24 fx/33 days without daily cisplatin: 26 pts. Group III: RT: 66 Gy/2.75 Gy/24 fx/33 days or 60 Gy/3 Gy/20 fx/26 days: 49 pts. Results The 1, 2, and 5 year actuarial overall survival (OS) were 46%, 24%, and 15%, respectively. At multivariate analysis the only factor with a significantly positive influence on OS was treatment with chemo-radiation (P = 0.024) (1-, 2-, and 5-yr OS 56%, 30% and 22% respectively). The incidence of local recurrence was 36%, the incidence of distant metastases 46%. Late complications grade 3 were seen in 21 pts and grade 4 in 4 patients. One patient had a lethal complication (oesophageal). For 32 patients insufficient data were available to assess late complications. Conclusion In this study we were able to reproduce the results of EORTC trial 08972/22973 in a non-selected patient population outside of the setting of a randomised trial. Radiotherapy (66 Gy/24 fx/33 days) combined with either concomitant daily low dose cisplatin or with two neo-adjuvant courses of gemcitabin and cisplatin are effective treatments for patients with locally advanced Non-Small Cell Lung Cancer. The concomitant schedule is also suitable for elderly people with co-morbidity.
- Published
- 2007
- Full Text
- View/download PDF
28. Role of quiescent cells in the homeostatic maintenance of the adult submandibular salivary gland.
- Author
-
Serrano Martinez P, Maimets M, Bron R, van Os R, de Haan G, Pringle S, and Coppes RP
- Abstract
Stem/progenitor cells are required for maintenance of salivary gland (SG) function and serve as untapped reservoirs to create functional cells. Despite recent advancements in the identification of stem/progenitor pools, in the submandibular gland (SMG), a knowledge gap remains. Furthermore, the contribution to adult SMG homeostasis of stem/progenitor cells originating from embryonic development is unclear. Here, we employ an H2B-GFP embryonic and adult pulse-and-chase system to characterize potential SMG stem/progenitor cells (SGSCs) based on quiescence at different stages. Phenotypical profiling of quiescent cells in the SMG revealed that label-retaining cells (LRCs) of embryonic or adult origin co-localized with CK8+ ductal or vimentin + mesenchymal, but not with CK5+ or CK14 + stem/progenitor cells. These SMG LRCs failed to self-renew in vitro while non-label retaining cells displayed differentiation and long-term expansion potential as organoids. Collectively, our data suggest that an active cycling population of cells is responsible for SMG homeostasis with organoid forming potential., Competing Interests: The authors declare no competing interests., (© 2022 The Authors.)
- Published
- 2022
- Full Text
- View/download PDF
29. Antifungal-Loaded Calcium Sulfate Beads as a Potential Therapeutic in Combating Candida auris.
- Author
-
Butcher MC, Brown JL, Hansom D, Wilson-Van Os R, Delury C, Laycock PA, and Ramage G
- Subjects
- Biofilms, Calcium Sulfate pharmacology, Candida, Humans, Antifungal Agents pharmacology, Antifungal Agents therapeutic use, Candida auris
- Abstract
Candida auris provides a substantial global nosocomial threat clinically. With the recent emergence that the organism can readily colonize skin niches, it will likely continue to pose a risk in health care units, particularly to patients undergoing surgery. The purpose of this study was to investigate the efficacy of antifungal-loaded calcium sulfate (CS) beads in combatting C. auris infection. We demonstrate that the CS-packed beads have the potential to interfere with planktonic and sessile C. auris.
- Published
- 2022
- Full Text
- View/download PDF
30. Assessing the Bioactive Profile of Antifungal-Loaded Calcium Sulfate against Fungal Biofilms.
- Author
-
Butcher MC, Brown JL, Hansom D, Wilson-van Os R, Delury C, Laycock PA, and Ramage G
- Subjects
- Biofilms, Fluconazole pharmacology, Microbial Sensitivity Tests, Antifungal Agents pharmacology, Calcium Sulfate pharmacology
- Abstract
Calcium sulfate (CS) has been used clinically as a bone- or void-filling biomaterial, and its resorptive properties have provided the prospect for its use as a release mechanism for local antibiotics to control biofilms. Here, we aimed to test CS beads loaded with three antifungal drugs against planktonic and sessile fungal species to assess whether these antifungal beads could be harnessed to provide consistent release of antifungals at biofilm-inhibitory doses. A panel of different fungal species ( n = 15) were selected for planktonic broth microdilution testing with fluconazole (FLZ), amphotericin B (AMB), and caspofungin (CSP). After establishing planktonic inhibition, antifungal CS beads were introduced to fungal biofilms ( n = 5) to assess biofilm formation and cell viability through a combination of standard quantitative and qualitative biofilm assays. Inoculation of a hydrogel substrate, packed with antifungal CS beads, was also used to assess diffusion through a semidry material, to mimic active infection in vivo In general, antifungals released from loaded CS beads were all effective at inhibiting the pathogenic fungi over 7 days within standard MIC ranges for these fungi. We observed a significant reduction of pregrown fungal biofilms across key fungal pathogens following treatment, with visually observable changes in cell morphology and biofilm coverage provided by scanning electron microscopy. Assessment of biofilm inhibition also revealed reductions in total and viable cells across all organisms tested. These data show that antifungal-loaded CS beads produce a sustained antimicrobial effect that inhibits and kills clinically relevant fungal species in vitro as planktonic and biofilm cells., (Copyright © 2021 Butcher et al.)
- Published
- 2021
- Full Text
- View/download PDF
31. Effects of environmental enrichment on forebrain neural plasticity and survival success of stocked Atlantic salmon.
- Author
-
Mes D, van Os R, Gorissen M, Ebbesson LOE, Finstad B, Mayer I, and Vindas MA
- Subjects
- Animals, Female, Fisheries, Male, Seasons, Aquaculture, Longevity, Neuronal Plasticity, Prosencephalon physiology, Salmo salar physiology
- Abstract
Fish reared for stocking programmes are severely stimulus deprived compared with their wild conspecifics raised under natural conditions. This leads to reduced behavioural plasticity and low post-release survival of stocked fish. Environmental enrichment can have positive effects on important life skills, such as predator avoidance and foraging behaviour, but the neural mechanisms underpinning these behavioural changes are still largely unknown. In this study, juvenile Atlantic salmon ( Salmo salar ) were reared in an enriched hatchery environment for 7 weeks, after which neurobiological characteristics and post-release survival were compared with those of fish reared under normal hatchery conditions. Using in situ hybridization and qPCR, we quantified the expression of brain-derived neurotrophic factor ( bdnf ) and the neural activity marker cfos in telencephalic subregions associated with relational memory, emotional learning and stress reactivity. Aside from lower expression of bdnf in the Dlv (a region associated with relational memory) of enriched salmon, we observed no other significant effects of enrichment in the studied regions. Exposure to an enriched environment increased post-release survival during a 5 month residence in a natural river by 51%. Thus, we demonstrate that environmental enrichment can improve stocking success of Atlantic salmon parr and that environmental enrichment is associated with changes in bdnf expression in the fish's hippocampus-equivalent structure., Competing Interests: Competing interestsThe authors declare no competing or financial interests., (© 2019. Published by The Company of Biologists Ltd.)
- Published
- 2019
- Full Text
- View/download PDF
32. Impact of Technique and Schedule of Reirradiation Plus Hyperthermia on Outcome after Surgery for Patients with Recurrent Breast Cancer.
- Author
-
Oldenborg S, van Os R, Oei B, and Poortmans P
- Abstract
Purpose: Combining reirradiation (reRT) with hyperthermia (HT) has shown to be of high therapeutic value for patients with loco-regionally recurrent breast cancer. The purpose of this study was to compare the long-term therapeutic effect and toxicity of reRT + HT following surgery of loco-regionally recurrent breast cancer using two different reRT regimens., Methods: The reRT regimen of the 78 patients treated in Institute A consisted of 8 × 4 Gy twice a week using mostly abutted photon-electron fields. The 78 patients treated in Institute B received a reRT regimen of 12 × 3 Gy, four times a week with single or multiple electron fields. Superficial hyperthermia was applied once a week in Institute A and twice a week in Institute B. Both institutes started HT treatment within 1 hour after reRT and used the same 434-MHz systems to heat the tumor area to 41-43 °C., Results: The 5-year-infield local control (LC) rates were similar; however, the 5-year-survival rates were 13% lower in Institute A. Most remarkable was the difference in risk with respect to 5-year ≥ grade 3 toxicity, which was more than twice as high in Institute A., Conclusion: The combination of reirradiation and hyperthermia after macroscopically complete excision of loco-regional breast cancer recurrences provides durable local control in patients at risk for locoregional recurrent breast cancer. Treatment is well tolerated with the 12 × 3 Gy schedule with limited-sized electron fields.
- Published
- 2019
- Full Text
- View/download PDF
33. Lifelong dietary intervention does not affect hematopoietic stem cell function.
- Author
-
Lazare S, Ausema A, Reijne AC, van Dijk G, van Os R, and de Haan G
- Subjects
- Aging, Animals, Caloric Restriction, Diet, High-Fat, Humans, Mice, Diet, Hematopoietic Stem Cells physiology
- Abstract
Hematopoietic stem cells (HSCs) undergo a profound functional decline during normal aging. Because caloric or dietary restriction has been shown to delay multiple aspects of the aging process in many species, we explored the consequences of lifelong caloric restriction, or conversely, lifelong excess caloric intake, on HSC numbers and function. Although caloric restriction prevented age-dependent increases in bone marrow cellularity, caloric restriction was not able to prevent functional decline of aged, long-term HSC functioning. A lifelong high-fat diet also did not affect HSC function. We conclude that lifelong caloric interventions fail to prevent or induce loss of age-associated HSC functioning., (Copyright © 2017 ISEH - International Society for Experimental Hematology. Published by Elsevier Inc. All rights reserved.)
- Published
- 2017
- Full Text
- View/download PDF
34. Human Salivary Gland Stem Cells Functionally Restore Radiation Damaged Salivary Glands.
- Author
-
Pringle S, Maimets M, van der Zwaag M, Stokman MA, van Gosliga D, Zwart E, Witjes MJ, de Haan G, van Os R, and Coppes RP
- Subjects
- Animals, Cell Differentiation genetics, Cell Differentiation radiation effects, Gene Expression Regulation, Developmental radiation effects, Humans, Mice, Proto-Oncogene Proteins c-kit genetics, Radiation, Salivary Glands metabolism, Salivary Glands transplantation, Single-Cell Analysis, Stem Cells cytology, Stem Cells metabolism, Stem Cells radiation effects, Xerostomia pathology, Proto-Oncogene Proteins c-kit biosynthesis, Salivary Glands cytology, Stem Cell Transplantation, Xerostomia therapy
- Abstract
Adult stem cells are often touted as therapeutic agents in the regenerative medicine field, however data detailing both the engraftment and functional capabilities of solid tissue derived human adult epithelial stem cells is scarce. Here we show the isolation of adult human salivary gland (SG) stem/progenitor cells and demonstrate at the single cell level in vitro self-renewal and differentiation into multilineage organoids. We also show in vivo functionality, long-term engraftment, and functional restoration in a xenotransplantation model. Indeed, transplanted human salisphere-derived cells restored saliva production and greatly improved the regenerative potential of irradiated SGs. Further selection for c-Kit expression enriched for cells with enhanced regenerative potencies. Interestingly, interaction of transplanted cells with the recipient SG may also be involved in functional recovery. Thus, we show for the first time that salispheres cultured from human SGs contain stem/progenitor cells capable of self-renewal and differentiation and rescue of saliva production. Our study underpins the therapeutic promise of salisphere cell therapy for the treatment of xerostomia., (© AlphaMed Press.)
- Published
- 2016
- Full Text
- View/download PDF
35. Long-Term In Vitro Expansion of Salivary Gland Stem Cells Driven by Wnt Signals.
- Author
-
Maimets M, Rocchi C, Bron R, Pringle S, Kuipers J, Giepmans BN, Vries RG, Clevers H, de Haan G, van Os R, and Coppes RP
- Subjects
- Animals, Antigens, Neoplasm metabolism, Cell Adhesion Molecules metabolism, Cell Culture Techniques, Cell Self Renewal, Cells, Cultured, Epithelial Cell Adhesion Molecule, Female, Mice, Inbred C57BL, Mice, Inbred NOD, Mice, Knockout, Mice, SCID, Mice, Transgenic, Microscopy, Confocal, Microscopy, Electron, Transmission, Radiation Injuries, Experimental therapy, Salivary Glands metabolism, Salivary Glands radiation effects, Spheroids, Cellular cytology, Spheroids, Cellular metabolism, Stem Cell Transplantation methods, Stem Cells metabolism, Stem Cells ultrastructure, Time Factors, beta Catenin metabolism, Cell Proliferation, Salivary Glands cytology, Stem Cells cytology, Wnt Signaling Pathway
- Abstract
Adult stem cells are the ultimate source for replenishment of salivary gland (SG) tissue. Self-renewal ability of stem cells is dependent on extrinsic niche signals that have not been unraveled for the SG. The ductal compartment in SG has been identified as the location harboring stem cells. Here, we report that rare SG ductal EpCAM(+) cells express nuclear β-catenin, indicating active Wnt signaling. In cell culture experiments, EpCAM(high) cells respond potently to Wnt signals stimulating self-renewal and long-term expansion of SG organoids, containing all differentiated SG cell types. Conversely, Wnt inhibition ablated long-term organoid cultures. Finally, transplantation of cells pre-treated with Wnt agonists into submandibular glands of irradiated mice successfully and robustly restored saliva secretion and increased the number of functional acini in vivo. Collectively, these results identify Wnt signaling as a key driver of adult SG stem cells, allowing extensive in vitro expansion and enabling restoration of SG function upon transplantation., (Copyright © 2016 The Authors. Published by Elsevier Inc. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF
36. Purification and ex vivo expansion of fully functional salivary gland stem cells.
- Author
-
Nanduri LS, Baanstra M, Faber H, Rocchi C, Zwart E, de Haan G, van Os R, and Coppes RP
- Subjects
- Animals, Cell Culture Techniques, Cell Differentiation, Cell Lineage, Cell Separation, Gene Expression Profiling, Gene Expression Regulation, Immunophenotyping, Mice, Stem Cells metabolism, Transcriptome, Salivary Glands cytology, Stem Cells cytology, Stem Cells physiology
- Abstract
Hyposalivation often leads to irreversible and untreatable xerostomia. Salivary gland (SG) stem cell therapy is an attractive putative option to salvage these patients but is impeded by the limited availability of adult human tissue. Here, using murine SG cells, we demonstrate single-cell self-renewal, differentiation, enrichment of SG stem cells, and robust in vitro expansion. Dependent on stem cell marker expression, SG sphere-derived single cells could be differentiated in vitro into distinct lobular or ductal/lobular organoids, suggestive of progenitor or stem cell potency. Expanded cells were able to form miniglands/organoids containing multiple SG cell lineages. Expansion of these multipotent cells through serial passaging resulted in selection of a cell population, homogenous for stem cell marker expression (CD24(hi)/CD29(hi)). Cells highly expressing CD24 and CD29 could be prospectively isolated and were able to efficiently restore radiation-damaged SG function. Our approach will facilitate the use of adult SG stem cells for a variety of scientific and therapeutic purposes., (Copyright © 2014 The Authors. Published by Elsevier Inc. All rights reserved.)
- Published
- 2014
- Full Text
- View/download PDF
37. Heterogeneity of young and aged murine hematopoietic stem cells revealed by quantitative clonal analysis using cellular barcoding.
- Author
-
Verovskaya E, Broekhuis MJ, Zwart E, Ritsema M, van Os R, de Haan G, and Bystrykh LV
- Subjects
- Age Factors, Animals, Cell Separation methods, Cells, Cultured, Clone Cells cytology, Clone Cells physiology, DNA Barcoding, Taxonomic methods, DNA Barcoding, Taxonomic statistics & numerical data, Hematopoietic Stem Cells physiology, High-Throughput Nucleotide Sequencing, Mice, Mice, Inbred C57BL, Models, Biological, Molecular Typing methods, Aging blood, Blood Donors, Cell Tracking methods, Cellular Senescence physiology, Clonal Evolution physiology, Hematopoietic Stem Cells cytology
- Abstract
The number of hematopoietic stem cells (HSCs) that contributes to blood formation and the dynamics of their clonal contribution is a matter of ongoing discussion. Here, we use cellular barcoding combined with multiplex high-throughput sequencing to provide a quantitative and sensitive analysis of clonal behavior of hundreds of young and old HSCs. The majority of transplanted clones steadily contributes to hematopoiesis in the long-term, although clonal output in granulocytes, T cells, and B cells is substantially different. Contributions of individual clones to blood are dynamically changing; most of the clones either expand or decline with time. Finally, we demonstrate that the pool of old HSCs is composed of multiple small clones, whereas the young HSC pool is dominated by fewer, but larger, clones.
- Published
- 2013
- Full Text
- View/download PDF
38. p38 inhibition and not MK2 inhibition enhances the secretion of chemokines from TNF-α activated rheumatoid arthritis fibroblast-like synoviocytes.
- Author
-
Dulos J, Wijnands FP, van den Hurk-van Alebeek JA, van Vugt MJ, Rullmann JA, Schot JJ, de Groot MW, Wagenaars JL, van Ravestein-van Os R, Smets RL, Vink PM, Hofstra CL, Nelissen RL, and van Eenennaam H
- Subjects
- Arthritis, Rheumatoid enzymology, Arthritis, Rheumatoid immunology, Cell Line, Chemokines immunology, Fibroblasts cytology, Fibroblasts metabolism, Humans, Imidazoles pharmacology, Intracellular Signaling Peptides and Proteins metabolism, MAP Kinase Signaling System drug effects, Monocytes cytology, Naphthalenes pharmacology, Primary Cell Culture, Protein Kinase Inhibitors pharmacology, Protein Serine-Threonine Kinases metabolism, Pyrazoles pharmacology, Pyridines pharmacology, Synovial Membrane cytology, Tumor Necrosis Factor-alpha immunology, Tumor Necrosis Factor-alpha metabolism, Up-Regulation drug effects, Up-Regulation immunology, p38 Mitogen-Activated Protein Kinases metabolism, Arthritis, Rheumatoid drug therapy, Chemokines metabolism, Enzyme Inhibitors pharmacology, Fibroblasts drug effects, Intracellular Signaling Peptides and Proteins antagonists & inhibitors, Protein Serine-Threonine Kinases antagonists & inhibitors, p38 Mitogen-Activated Protein Kinases antagonists & inhibitors
- Abstract
Objectives: For many years the p38 MAP kinase (MAPK) has been a major anti-inflammatory target for the development of an oral therapy for rheumatoid arthritis (RA). However, disappointing results from Phase II clinical studies suggest that adaptations may occur, which allow escape from blockade of the p38 pathway. In this study we investigated whether p38 inhibition mediated JNK activation represents such an escape mechanism., Methods: Interaction between the JNK and p38 pathways was studied in TNF-α stimulated THP-1 monocytes, primary macrophages and fibroblast-like synoviocytes from OA and RA patients using pharmacological inhibitors and siRNAs., Results: TNF-α induced phosphorylation of JNK and c-Jun was sustained by p38 inhibitors in monocytes, primary macrophages and FLS. Upregulation of Mip1α, Mip1β and IL-8 mRNAs and protein were observed upon p38 inhibition. More importantly, inhibition of MK2, the substrate of p38 did not sustain JNK activation upon TNF-α activation and did not elevate Mip1α, Mip1β and IL-8 chemokines as compared to TNF-α alone. In this study, TNF-α or IL-1β induced JNK activation is sustained by p38 inhibition, resulting in enhanced chemokine secretion., Conclusions: Based on the suggested role of these chemokines in RA pathogenesis, the upregulation of these chemokines may provide an explanation for the lack of efficacy of p38 inhibitors in Phase II. The absence of any effect of MK2 inhibition in our models on this mechanism, while coming with similar efficacy on blocking p38, provides support for further investigations to reveal the potential of MK2 inhibition as a novel treatment of RA.
- Published
- 2013
39. Concise review: Adult salivary gland stem cells and a potential therapy for xerostomia.
- Author
-
Pringle S, Van Os R, and Coppes RP
- Subjects
- Animals, Cell- and Tissue-Based Therapy methods, Humans, Models, Biological, Stem Cell Transplantation methods, Salivary Glands pathology, Xerostomia therapy
- Abstract
The ability to speak, swallow, masticate, taste food, and maintain a healthy oral cavity is heavily reliant on the presence of saliva, the hugely important effect of which on our everyday lives is often unappreciated. Hyposalivation, frequently experienced by people receiving radiation therapy for head and neck cancers, results in a plethora of symptoms whose combined effect can drastically reduce quality of life. Although artificial lubricants and drugs stimulating residual function are available to ameliorate the consequences of hyposalivation, their effects are at best transient. Such management techniques do not address the source of the problem: a lack of functional saliva-producing acinar cells, resulting from radiation-induced stem cell sterilization. Post-radiotherapy stimulation of cell proliferation only results in improved saliva secretion when part of the tissue has been spared or when the dose to the salivary gland (SG) remains below a certain level. Therefore, stem cell replacement therapy may be a good option to treat radiation-induced hyposalivation. Substantial progress has been made lately in the understanding of cell turnover in the SG, and the recent identification of stem and progenitor cell populations in the SG provides a basis for studies toward development of a stem cell-based therapy for xerostomia. Here, we review the current state of knowledge of SG stem cells and their potential for use in a cell-based therapy that may provide a more durable cure for hyposalivation., (Copyright © 2013 AlphaMed Press.)
- Published
- 2013
- Full Text
- View/download PDF
40. Sca-1 is an early-response target of histone deacetylase inhibitors and marks hematopoietic cells with enhanced function.
- Author
-
Walasek MA, Bystrykh LV, Olthof S, de Haan G, and van Os R
- Subjects
- Animals, Cell Differentiation drug effects, Dose-Response Relationship, Drug, Female, Hematopoietic Stem Cells cytology, Mice, Mice, Inbred C57BL, Antigens, Ly physiology, Hematopoietic Stem Cells drug effects, Histone Deacetylase Inhibitors pharmacology, Membrane Proteins physiology, Valproic Acid pharmacology
- Abstract
Histone deacetylase inhibitors (HDIs) have been shown to enhance hematopoietic stem and progenitor cell activity and improve stem cell outcomes after ex vivo culture. Identification of gene targets of HDIs is required to understand the full potential of these compounds and can allow for improved stem cell culturing protocols. The molecular process that underlies the biological effects of valproic acid (VPA), a widely used HDI, on hematopoietic stem/progenitor cells was investigated by studying the early-response genes of VPA. These genes were linked to VPA-induced enhancement of cell function as measured by in vitro assays. Genome-wide gene expression studies revealed over-representation of genes involved in glutathione metabolism, receptor and signal transducer activity, and changes in the hematopoietic stem/progenitor cells surface profile after short, 24-hour VPA treatment. Sca-1, a well-known and widely used stem cell surface marker, was identified as a prominent VPA target. We showed that multiple HDIs induce Sca-1 expression on hematopoietic cells. VPA strongly preserved Sca-1 expression on Lin(-)Sca1(+)ckit(+) cells, but also reactivated Sca-1 on committed progenitor cells that were Sca-1(neg), thereby reverting them to the Lin(-)Sca1(+)ckit(+) phenotype. We demonstrated that reacquired Sca-1 expression coincided with induced self-renewal capacity as measured by in vitro replating assays, while Sca-1 itself was not required for the biological effects of VPA as demonstrated using Sca-1-deficient progenitor cells. In conclusion, our results show that VPA modulates several genes involved in multiple signal transduction pathways, of which Sca-1 was shown to mark cells with increased self-renewal capacity in response to HDIs., (Copyright © 2013 ISEH - Society for Hematology and Stem Cells. Published by Elsevier Inc. All rights reserved.)
- Published
- 2013
- Full Text
- View/download PDF
41. Kruppel-like factor 7 overexpression suppresses hematopoietic stem and progenitor cell function.
- Author
-
Schuettpelz LG, Gopalan PK, Giuste FO, Romine MP, van Os R, and Link DC
- Subjects
- Animals, Apoptosis, Biomarkers, Tumor genetics, Biomarkers, Tumor metabolism, Blotting, Western, Cell Differentiation, Cell Proliferation, Cyclin-Dependent Kinase Inhibitor p21 genetics, Cyclin-Dependent Kinase Inhibitor p21 metabolism, Female, Flow Cytometry, Gene Expression Profiling, Hematopoiesis, Hematopoietic Stem Cells metabolism, Lymphoid Progenitor Cells metabolism, Male, Mice, Mice, Inbred C57BL, Mice, Knockout, Myeloid Progenitor Cells metabolism, Oligonucleotide Array Sequence Analysis, RNA, Messenger genetics, Real-Time Polymerase Chain Reaction, Reverse Transcriptase Polymerase Chain Reaction, Stem Cells metabolism, T-Lymphocytes metabolism, Hematopoietic Stem Cells pathology, Kruppel-Like Transcription Factors physiology, Lymphoid Progenitor Cells pathology, Myeloid Progenitor Cells pathology, Stem Cells pathology, T-Lymphocytes pathology
- Abstract
Increased expression of Kruppel-like factor 7 (KLF7) is an independent predictor of poor outcome in pediatric acute lymphoblastic leukemia. The contribution of KLF7 to hematopoiesis has not been previously described. Herein, we characterized the effect on murine hematopoiesis of the loss of KLF7 and enforced expression of KLF7. Long-term multilineage engraftment of Klf7(-/-) cells was comparable with control cells, and self-renewal, as assessed by serial transplantation, was not affected. Enforced expression of KLF7 results in a marked suppression of myeloid progenitor cell growth and a loss of short- and long-term repopulating activity. Interestingly, enforced expression of KLF7, although resulting in multilineage growth suppression that extended to hematopoietic stem cells and common lymphoid progenitors, spared T cells and enhanced the survival of early thymocytes. RNA expression profiling of KLF7-overexpressing hematopoietic progenitors identified several potential target genes mediating these effects. Notably, the known KLF7 target Cdkn1a (p21(Cip1/Waf1)) was not induced by KLF7, and loss of CDKN1A does not rescue the repopulating defect. These results suggest that KLF7 is not required for normal hematopoietic stem and progenitor function, but increased expression, as seen in a subset of lymphoid leukemia, inhibits myeloid cell proliferation and promotes early thymocyte survival.
- Published
- 2012
- Full Text
- View/download PDF
42. Impaired survival and long-term neurological problems in benign meningioma.
- Author
-
van Alkemade H, de Leau M, Dieleman EM, Kardaun JW, van Os R, Vandertop WP, van Furth WR, and Stalpers LJ
- Subjects
- Adolescent, Adult, Aged, Child, Child, Preschool, Female, Follow-Up Studies, Humans, Male, Meningeal Neoplasms complications, Meningeal Neoplasms therapy, Meningioma complications, Meningioma therapy, Middle Aged, Neoplasm Grading, Nervous System Diseases therapy, Prognosis, Retrospective Studies, Survival Rate, Young Adult, Meningeal Neoplasms mortality, Meningioma mortality, Nervous System Diseases etiology, Nervous System Diseases mortality, Survivors statistics & numerical data
- Abstract
Purpose: To assess long-term functional outcome and survival among patients with meningioma World Health Organization (WHO) grade I., Methods: Retrospective analysis of 205 patients after resection of WHO grade I intracranial meningioma from 1985 through 2003. Expected age- and sex-specific survival was calculated by applying Dutch life-table statistics to each patient for the individual duration of follow-up. Long-term functional outcome was assessed using a mailed questionnaire to the general practitioner., Results: The mean duration of follow-up was 11.5 years. Survival at 5, 10, 15, and 20 years was 92%, 81%, 63%, and 53%, respectively, which is significantly lower than the expected survival (94%, 86%, 78%, and 66%, respectively). Survival was worse with higher age (P < .001). Survival among patients younger than 45 years and older than 65 years was comparable to the expected survival but significantly worse among patients aged 45-65 years. Analysis of the cause of death suggests an excess mortality associated with both brain tumor death and stroke (P = .07). Recurrence rates at 5, 10, and 15 years were 18%, 26%, and 32%, respectively. Higher Simpson grade (P < .001) and lower age (P = .02) were associated with a higher recurrence rate. In 29 patients (14%) receiving radiotherapy, the 5-year recurrence rate was 18% and the 5-year survival was only 58%. Long-term functioning (≥ 5 years after last treatment) could be assessed in 89 long-term survivors: 29 patients (33%) showed no deficits, and 60 (67%) showed at least 1 neurological symptom, of whom 24 (27%) were unable to perform normal daily activities., Conclusion: Long-term survival in WHO grade I meningioma is challenged in patients more than 45 years of age. Excess mortality seems to be associated with both tumor recurrence and stroke. The majority of patients have long-term neurological problems.
- Published
- 2012
- Full Text
- View/download PDF
43. The combination of valproic acid and lithium delays hematopoietic stem/progenitor cell differentiation.
- Author
-
Walasek MA, Bystrykh L, van den Boom V, Olthof S, Ausema A, Ritsema M, Huls G, de Haan G, and van Os R
- Subjects
- Animals, Cell Differentiation physiology, Cells, Cultured, Drug Combinations, Drug Evaluation, Preclinical, Drug Interactions, Female, Hematopoiesis physiology, Hematopoietic Stem Cells physiology, Lithium administration & dosage, Mice, Mice, Inbred C57BL, Myeloid Cells drug effects, Myeloid Cells physiology, Phenotype, Time Factors, Valproic Acid administration & dosage, Cell Differentiation drug effects, Hematopoiesis drug effects, Hematopoietic Stem Cells drug effects, Lithium pharmacology, Valproic Acid pharmacology
- Abstract
Despite increasing knowledge on the regulation of hematopoietic stem/progenitor cell (HSPC) self-renewal and differentiation, in vitro control of stem cell fate decisions has been difficult. The ability to inhibit HSPC commitment in culture may be of benefit to cell therapy protocols. Small molecules can serve as tools to manipulate cell fate decisions. Here, we tested 2 small molecules, valproic acid (VPA) and lithium (Li), to inhibit differentiation. HSPCs exposed to VPA and Li during differentiation-inducing culture preserved an immature cell phenotype, provided radioprotection to lethally irradiated recipients, and enhanced in vivo repopulating potential. Anti-differentiation effects of VPA and Li were observed also at the level of committed progenitors, where VPA re-activated replating activity of common myeloid progenitor and granulocyte macrophage progenitor cells. Furthermore, VPA and Li synergistically preserved expression of stem cell-related genes and repressed genes involved in differentiation. Target genes were collectively co-regulated during normal hematopoietic differentiation. In addition, transcription factor networks were identified as possible primary regulators. Our results show that the combination of VPA and Li potently delays differentiation at the biologic and molecular levels and provide evidence to suggest that combinatorial screening of chemical compounds may uncover possible additive/synergistic effects to modulate stem cell fate decisions.
- Published
- 2012
- Full Text
- View/download PDF
44. Genetic screen identifies microRNA cluster 99b/let-7e/125a as a regulator of primitive hematopoietic cells.
- Author
-
Gerrits A, Walasek MA, Olthof S, Weersing E, Ritsema M, Zwart E, van Os R, Bystrykh LV, and de Haan G
- Subjects
- Animals, Biomarkers metabolism, Cells, Cultured, Erythroid Cells cytology, Female, Male, Mice, Mice, Inbred C57BL, Mice, Inbred CBA, Myeloid Cells cytology, Oligonucleotide Array Sequence Analysis, Real-Time Polymerase Chain Reaction, Erythroid Cells metabolism, Gene Expression Profiling, Hematopoietic Stem Cells physiology, MicroRNAs genetics, Myeloid Cells metabolism
- Abstract
Hematopoietic stem/progenitor cell (HSPC) traits differ between genetically distinct mouse strains. For example, DBA/2 mice have a higher HSPC frequency compared with C57BL/6 mice. We performed a genetic screen for micro-RNAs that are differentially expressed between LSK, LS(-)K(+), erythroid and myeloid cells isolated from C57BL/6 and DBA/2 mice. This analysis identified 131 micro-RNAs that were differentially expressed between cell types and 15 that were differentially expressed between mouse strains. Of special interest was an evolutionary conserved miR cluster located on chromosome 17 consisting of miR-99b, let-7e, and miR-125a. All cluster members were most highly expressed in LSKs and down-regulated upon differentiation. In addition, these microRNAs were higher expressed in DBA/2 cells compared with C57BL/6 cells, and thus correlated with HSPC frequency. To functionally characterize these microRNAs, we overexpressed the entire miR-cluster 99b/let-7e/125a and miR-125a alone in BM cells from C57BL/6 mice. Overexpression of the miR-cluster or miR-125a dramatically increased day-35 CAFC activity and caused severe hematopoietic phenotypes upon transplantation. We showed that a single member of the miR-cluster, namely miR-125a, is responsible for the majority of the observed miR-cluster overexpression effects. Finally, we performed genome-wide gene expression arrays and identified candidate target genes through which miR-125a may modulate HSPC fate.
- Published
- 2012
- Full Text
- View/download PDF
45. BMI1 collaborates with BCR-ABL in leukemic transformation of human CD34+ cells.
- Author
-
Rizo A, Horton SJ, Olthof S, Dontje B, Ausema A, van Os R, van den Boom V, Vellenga E, de Haan G, and Schuringa JJ
- Subjects
- Animals, Cell Line, Tumor, Cell Proliferation, Cell Transformation, Neoplastic genetics, Cell Transformation, Neoplastic pathology, Female, Fusion Proteins, bcr-abl genetics, Gene Expression, Gene Expression Regulation, Leukemic, Hematopoietic Stem Cells metabolism, Hematopoietic Stem Cells pathology, Humans, Leukemia, Myelogenous, Chronic, BCR-ABL Positive etiology, Leukemia, Myelogenous, Chronic, BCR-ABL Positive genetics, Leukemia, Myelogenous, Chronic, BCR-ABL Positive pathology, Mice, Mice, SCID, Nuclear Proteins genetics, Polycomb Repressive Complex 1, Proto-Oncogene Proteins genetics, Repressor Proteins genetics, Tumor Cells, Cultured, Antigens, CD34 metabolism, Cell Transformation, Neoplastic metabolism, Fetal Blood cytology, Fusion Proteins, bcr-abl metabolism, Leukemia, Myelogenous, Chronic, BCR-ABL Positive metabolism, Nuclear Proteins metabolism, Proto-Oncogene Proteins metabolism, Repressor Proteins metabolism
- Abstract
The major limitation for the development of curative cancer therapies has been an incomplete understanding of the molecular mechanisms driving cancer progression. Human models to study the development and progression of chronic myeloid leukemia (CML) have not been established. Here, we show that BMI1 collaborates with BCR-ABL in inducing a fatal leukemia in nonobese diabetic/severe combined immunodeficiency mice transplanted with transduced human CD34(+) cells within 4-5 months. The leukemias were transplantable into secondary recipients with a shortened latency of 8-12 weeks. Clonal analysis revealed that similar clones initiated leukemia in primary and secondary mice. In vivo, transformation was biased toward a lymphoid blast crisis, and in vitro, myeloid as well as lymphoid long-term, self-renewing cultures could be established. Retroviral introduction of BMI1 in primary chronic-phase CD34(+) cells from CML patients elevated their proliferative capacity and self-renewal properties. Thus, our data identify BMI1 as a potential therapeutic target in CML.
- Published
- 2010
- Full Text
- View/download PDF
46. Engraftment of syngeneic bone marrow is not more efficient after intrafemoral transplantation than after traditional intravenous administration.
- Author
-
van Os R, Ausema A, Dontje B, van Riezen M, van Dam G, and de Haan G
- Subjects
- Animals, Bone Marrow Cells cytology, Bone Marrow Cells metabolism, Female, Femur surgery, Flow Cytometry, Hematopoietic Stem Cells cytology, Injections, Intravenous, Luciferases genetics, Luciferases metabolism, Luminescent Measurements methods, Male, Mice, Mice, Inbred C57BL, Mice, Inbred Strains, Mice, Transgenic, Time Factors, Transplantation Chimera blood, Transplantation, Isogeneic, Whole-Body Irradiation, Bone Marrow surgery, Hematopoietic Stem Cell Transplantation methods, Hematopoietic Stem Cells metabolism
- Abstract
Objective: Hematopoietic stem cells are key elements for life-long production of mature blood cells. The success of clinical stem cell transplantation may be improved when the number of stem cells that engraft after transplantation can be increased. Here, we investigated in a syngeneic mouse model whether engraftment and reconstitution can be improved by transplantation directly into the bone marrow., Materials and Methods: In this study, we directly compared syngeneic transplantation of hematopoietic stem cells into the bone marrow with intravenous administration and assessed reconstitution kinetics and engraftment by bioluminescent imaging and chimerism determination., Results: Surprisingly, only about 10% of cells injected directly into the femur (intrafemoral, IF) could be retrieved within 5 minutes after injection. Only in the first 48 hours after transplantation, engraftment in IF-transplanted animals was higher compared with intravenous injection. However, at all later time points no differences could be detected using whole body bioluminescence or measuring blood cell reconstitution. Most importantly, we found that IF-transplanted cells did not outcompete cells transplanted intravenously when cotransplanted in the same recipient., Conclusions: In conclusion, IF transplantation in a murine syngeneic setting revealed no enhanced engraftment. Previous reports on IF transplantation may have relied on escape from immune rejection in xenogeneic or allogeneic models. Therefore, we conclude that stem cells can find the proper microenvironment irrespective of the route of administration., (Copyright © 2010 ISEH - Society for Hematology and Stem Cells. Published by Elsevier Inc. All rights reserved.)
- Published
- 2010
- Full Text
- View/download PDF
47. Hematopoietic stem cell quiescence: yet another role for p53.
- Author
-
van Os R, de Haan G, and Dykstra BJ
- Subjects
- Animals, Cell Proliferation, Cyclin-Dependent Kinase Inhibitor p21 metabolism, DNA-Binding Proteins deficiency, DNA-Binding Proteins metabolism, Hematopoietic Stem Cells metabolism, Mice, Models, Biological, Nerve Tissue Proteins metabolism, Nuclear Proteins metabolism, Transcription Factors deficiency, Transcription Factors metabolism, Hematopoietic Stem Cells cytology, Tumor Suppressor Protein p53 metabolism
- Abstract
p53, sometimes referred to as the "guardian of the genome," helps regulate cell-cycle arrest, DNA-damage repair, apoptosis, and senescence. Adding to this list, in this issue of Cell Stem Cell, Liu et al. (2009) show that p53 also plays a role in regulating hematopoietic stem cell quiescence.
- Published
- 2009
- Full Text
- View/download PDF
48. A Limited role for p21Cip1/Waf1 in maintaining normal hematopoietic stem cell functioning.
- Author
-
van Os R, Kamminga LM, Ausema A, Bystrykh LV, Draijer DP, van Pelt K, Dontje B, and de Haan G
- Subjects
- Animals, Bone Marrow Cells cytology, Bone Marrow Cells drug effects, Bone Marrow Cells physiology, Bone Marrow Cells radiation effects, Cell Count, Cell Cycle radiation effects, Cell Division, Crosses, Genetic, Cyclin-Dependent Kinase Inhibitor p21 deficiency, Cyclin-Dependent Kinase Inhibitor p21 genetics, Embryo, Mammalian, Fibroblasts cytology, Fibroblasts physiology, Flow Cytometry, Fluorouracil pharmacology, Hematopoietic Stem Cell Transplantation methods, Hematopoietic Stem Cells cytology, Hematopoietic Stem Cells drug effects, Hematopoietic Stem Cells radiation effects, Mice, Mice, Inbred C57BL, Mice, Inbred Strains, Mice, Knockout, Cyclin-Dependent Kinase Inhibitor p21 physiology, Hematopoietic Stem Cells physiology
- Abstract
Several studies have suggested that the cyclin-dependent kinase (CDK) inhibitor p21 plays a crucial role in regulating hematopoietic stem and progenitor pool size. To allow assessment of long-term stem cell functioning in vivo, we have backcrossed a p21 null allele to C57BL/6 (B6) mice, the most commonly used mouse strain in hematopoietic stem cell research. In various in vitro assays, the homozygous deletion of the p21 allele did not affect the number of hematopoietic cells in B6 mice. Furthermore, the competitive repopulation ability was not different between p21-deficient and wild-type stem cells from both young and aged (20-month-old) mice. These results show that p21 is not essential for regulation of stem cell number in steady state. When proliferative stress was applied on p21-deficient stem cells by serial transplantation of 1,500 Lin(-)Sca-1(+)c-kit(+) (LSK) cells, again no detrimental effect was observed on cobblestone area-forming cell (CAFC) frequency and competitive repopulating ability. However, when bone marrow cells from mice that received 2 Gy of irradiation were transplanted, p21 deficiency resulted in a more than fourfold reduction in competitive repopulation index. Finally, we did not find major differences in cell cycle status and global gene expression patterns between LSK cells from p21-deficient and wild-type mice. Our findings indicate that the background of mice used for studying the function of a gene by genetic modification may determine the outcome. Cumulatively, our data fail to support the notion that p21 is essential for stem cell function during steady-state hematopoiesis, but may be relatively more important under conditions of cellular stress.
- Published
- 2007
- Full Text
- View/download PDF
49. Fibroblast growth factor-1 and -2 preserve long-term repopulating ability of hematopoietic stem cells in serum-free cultures.
- Author
-
Yeoh JS, van Os R, Weersing E, Ausema A, Dontje B, Vellenga E, and de Haan G
- Subjects
- Animals, Cell Culture Techniques, Cell Proliferation, Coculture Techniques, Colony-Forming Units Assay, Culture Media, Serum-Free, Female, Growth Substances pharmacology, Hematopoietic Stem Cell Transplantation, Hematopoietic Stem Cells classification, Humans, Kinetics, Mice, Mice, Inbred C57BL, Radiation Tolerance, Recombinant Proteins pharmacology, Fibroblast Growth Factor 1 pharmacology, Fibroblast Growth Factor 2 pharmacology, Hematopoietic Stem Cells cytology, Hematopoietic Stem Cells drug effects
- Abstract
In this study, we demonstrate that extended culture of unfractionated mouse bone marrow (BM) cells, in serum-free medium, supplemented only with fibroblast growth factor (FGF)-1, FGF-2, or FGF-1 +2 preserves long-term repopulating hematopoietic stem cells (HSCs). Using competitive repopulation assays, high levels of stem cell activity were detectable at 1, 3, and 5 weeks after initiation of culture. FGFs as single growth factors failed to support cultures of highly purified Lin(-)Sca-1(+)c-Kit(+)(LSK) cells. However, cocultures of purified CD45.1 LSK cells with whole BM CD45.2 cells provided high levels of CD45.1 chimerism after transplant, showing that HSC activity originated from LSK cells. Subsequently, we tested the reconstituting potential of cells cultured in FGF-1 + 2 with the addition of early acting stimulatory molecules, stem cell factor +interleukin-11 + Flt3 ligand. The addition of these growth factors resulted in a strong mitogenic response, inducing rapid differentiation and thereby completely overriding FGF-dependent stem cell conservation. Importantly, although HSC activity is typically rapidly lost after short-term culture in vitro, our current protocol allows us to sustain stem cell repopulation potential for periods up to 5 weeks.
- Published
- 2006
- Full Text
- View/download PDF
50. Serpina1 is a potent inhibitor of IL-8-induced hematopoietic stem cell mobilization.
- Author
-
van Pel M, van Os R, Velders GA, Hagoort H, Heegaard PM, Lindley IJ, Willemze R, and Fibbe WE
- Subjects
- Animals, Antibodies, Monoclonal chemistry, Antibodies, Monoclonal metabolism, Blotting, Western, Bone Marrow pathology, Cell Adhesion, Cytokines metabolism, Dose-Response Relationship, Radiation, Male, Mice, Mice, Inbred BALB C, Mice, Inbred C57BL, Models, Biological, Pancreatic Elastase metabolism, Protease Inhibitors metabolism, Protease Inhibitors pharmacology, RNA, Messenger metabolism, Reverse Transcriptase Polymerase Chain Reaction, Stem Cells cytology, Time Factors, alpha 1-Antitrypsin metabolism, Hematopoietic Stem Cell Mobilization methods, Hematopoietic Stem Cells cytology, Interleukin-8 antagonists & inhibitors, Interleukin-8 metabolism, alpha 1-Antitrypsin physiology
- Abstract
Here, we report that cytokine-induced (granulocyte colony-stimulating factor and IL-8) hematopoietic stem cell (HSC) and hematopoietic progenitor cell (HPC) mobilization is completely inhibited after low-dose (0.5 Gy) total-body irradiation (TBI). Because neutrophil granular proteases are regulatory mediators in cytokine-induced HSC/HPC mobilization, we considered a possible role for protease inhibitors in the induction of HSC/HPC mobilization. Bone marrow (BM) extracellular extracts that were obtained from murine femurs after 0.5 Gy of TBI contained an inhibitor of elastase. Also, after low-dose TBI, both Serpina1 mRNA and protein concentrations were increased in BM extracts, compared with extracts that were obtained from controls. The inhibitory activity in BM extracts of irradiated mice was reversed by addition of an Ab directed against Serpina1. To further study a possible in vivo role of Serpina1 in HSC/HPC mobilization, we administered Serpina1 before IL-8 injection. This administration resulted in an almost complete inhibition of HSC/HPC mobilization, whereas heat-inactivated Serpina1 had no effect. These results indicate that low-dose TBI inhibits cytokine-induced HSC/HPC mobilization and induces Serpina1 in the BM. Because exogenous administration of Serpina1 inhibits mobilization, we propose that radiation-induced Serpina1 is responsible for the inhibition of HSC/HPC mobilization. Also, we hypothesize that cytokine-induced HSC/HPC mobilization is determined by a critical balance between serine proteases and serine protease inhibitors.
- Published
- 2006
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.